The largest database of trusted experimental protocols

Si srsf1

Manufactured by GenePharma
Sourced in China

The Si-SRSF1 is a laboratory equipment designed for the knockdown of SRSF1 gene expression. It utilizes small interfering RNA (siRNA) technology to target and silence the SRSF1 gene, which plays a role in the regulation of RNA splicing. The core function of the Si-SRSF1 is to provide a tool for researchers to investigate the effects of SRSF1 knockdown in various experimental models and research applications.

Automatically generated - may contain errors

2 protocols using si srsf1

1

In vitro DITD Model Establishment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse spermatogenic GC-1 spg cell line was purchased from the American Tissue Culture Collection (Shanghai, China) and cultured in Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen, Waltham, MA, USA) containing 10% fatal bovine serum (Invitrogen) at 37°C with 5% CO2. To establish a DITD model in vitro, GC-1 spg cells were stimulated by 30 mmol/L of glucose (Invitrogen) for 24 hours. Small interfering (si) RNAs targeting METTL3 (si-METTL3), serine and arginine rich splicing factor 1 (SRSF1; si-SRSF1), pcDNA3.1-METTL3, pcDNA3.1-TUG1, and corresponding scrambled controls were purchased from GenePharma. Target plasmid vectors or negative controls were transfected to GC-1 spg cells using Lipofectamine 3000 (Invitrogen).
+ Open protocol
+ Expand
2

GC Cell Line Transfection and Maintenance

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human GC cell line SGC-7901 (American Type Culture Collection, ATCC, Manassas, VA, USA) was maintained in the Roswell Park Memorial Institute (RPMI)-1640 (South Logan, UT, USA) with 10% fetal bovine serum (Tianhang Biotechnology Co., Ltd., Zhejiang, China) and 100 units/ml penicillin/streptomycin in an incubator with 5% CO2 at 37 °C. The medium was renewed every 24—48 h. The cells exhibiting logarithmic growth were subsequently detached using 0.25% trypsin and transfected with CCL21 (150 μg·L−1 CCL21, ZSGB-Bio, Beijing, China), oe-MALAT1-1, si-MALAT1-1, si-MALAT1-2, or si-SRSF1 (the above plasmids designed, synthesized and constructed by Shanghai GenePharma Co. Ltd., Shanghai, China) in accordance with the instructions of the LipofectamineTM2000 (Invitrogen, Carlsbad, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!